ServiceXS started as a small company in May 2002 with two employees. A close collaboration with the Leiden Genome Technology Center (LGTC), an internal facility of Leiden University Medical Center (LUMC), was established in order to get access to state-of-the-art equipment and technologies. This collaboration enabled ServiceXS to offer innovative genomic services to the Life Sciences market.
ServiceXS started providing services such as the production of home spotted microarrays, gene expression projects (home spotted, Agilent, Affymetrix), conventional sequencing, Taqman® qPCR (Applied Biosystems), cloning, and also training and consultancy. The quote “ServiceXS, your outsourcing partner” appeared to be very successful as we rapidly grew and added new services in the field of Genotyping, Gene expression (whole genome and focussed), Proteomics and Next Generation Sequencing. This in close collaboration with major suppliers (Fluidigm, Idaho, Illumina).
The company has always been innovative: we were the first Agilent service provider in Europe, the first service provider to offer Solexa services (now the Illumina Next Generation Sequencing) in Europe, and the first Fluidigm service provider world wide.
At the moment ServiceXS offers the broadest portfolio of challenging and innovative services and is a major service provider not only to academic research centers, but also to biotech and agrotech companies all over the world.
Since spring 2011, ServiceXS received the ISO/IEC 17025 accreditation. Although our entire laboratory is organized according to these guidelines, the exact services that fall within the accreditations cope can be found on the RvA website (ServiceXS registration number L518). Our accreditation scope was broad to begin with, but is expanding still. We are the only service provider in Europe to offer DNA next generation sequencing under the accreditation scope.